BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 23485740)

  • 1. Neurosteroid allopregnanolone attenuates development of nicotine withdrawal behavior in mice.
    Thakre PP; Tundulwar MR; Chopde CT; Ugale RR
    Neurosci Lett; 2013 Apr; 541():144-9. PubMed ID: 23485740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic progesterone treatment augments while dehydroepiandrosterone sulphate prevents tolerance to ethanol anxiolysis and withdrawal anxiety in rats.
    Sharma AN; Chopde CT; Hirani K; Kokare DM; Ugale RR
    Eur J Pharmacol; 2007 Jul; 567(3):211-22. PubMed ID: 17511983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal neurosteroid levels are determinant in shaping adult prepulse inhibition response to hippocampal allopregnanolone in rats.
    Darbra S; Modol L; Vallée M; Pallarès M
    Psychoneuroendocrinology; 2013 Aug; 38(8):1397-406. PubMed ID: 23294582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic agmatine treatment prevents behavioral manifestations of nicotine withdrawal in mice.
    Kotagale NR; Chopde CT; Umekar MJ; Taksande BG
    Eur J Pharmacol; 2015 May; 754():190-8. PubMed ID: 25744879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiolytic activity of progesterone in progesterone receptor knockout mice.
    Reddy DS; O'Malley BW; Rogawski MA
    Neuropharmacology; 2005 Jan; 48(1):14-24. PubMed ID: 15617723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of progesterone metabolism mimics the effect of progesterone withdrawal on forced swim test immobility.
    Beckley EH; Finn DA
    Pharmacol Biochem Behav; 2007 Oct; 87(4):412-9. PubMed ID: 17597197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurosteroid withdrawal model of perimenstrual catamenial epilepsy.
    Reddy DS; Kim HY; Rogawski MA
    Epilepsia; 2001 Mar; 42(3):328-36. PubMed ID: 11442149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of acupuncture on anxiety-like behavior during nicotine withdrawal and relevant mechanisms.
    Chae Y; Yeom M; Han JH; Park HJ; Hahm DH; Shim I; Lee HS; Lee H
    Neurosci Lett; 2008 Jan; 430(2):98-102. PubMed ID: 18060697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal finasteride induces anxiogenic-like profile and deteriorates passive avoidance in adulthood after intrahippocampal neurosteroid administration.
    Martín-García E; Darbra S; Pallarés M
    Neuroscience; 2008 Jul; 154(4):1497-505. PubMed ID: 18539400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurosteroid coadministration prevents development of tolerance and augments recovery from benzodiazepine withdrawal anxiety and hyperactivity in mice.
    Reddy DS; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1997; 19(6):395-405. PubMed ID: 9385589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Rhodiola rosea L. extract on affective and physical signs of nicotine withdrawal in mice.
    Mattioli L; Perfumi M
    J Psychopharmacol; 2011 Mar; 25(3):402-10. PubMed ID: 19939867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replacement with GABAergic steroid precursors restores the acute ethanol withdrawal profile in adrenalectomy/gonadectomy mice.
    Kaufman KR; Tanchuck MA; Strong MN; Finn DA
    Neuroscience; 2010 Mar; 166(1):5-14. PubMed ID: 20004707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of spontaneous and precipitated nicotine withdrawal in the mouse.
    Damaj MI; Kao W; Martin BR
    J Pharmacol Exp Ther; 2003 Nov; 307(2):526-34. PubMed ID: 12970387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of the expression of mecamylamine-precipitated nicotine withdrawal by calcium channel antagonists.
    Biala G; Weglinska B
    Pharmacol Res; 2005 May; 51(5):483-8. PubMed ID: 15749464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local changes in neurosteroid levels in the substantia nigra reticulata and the ventral tegmental area alter chronic ethanol withdrawal severity in male withdrawal seizure-prone mice.
    Tanchuck MA; Cozzoli DK; He I; Kaufman KR; Snelling C; Crabbe JC; Mark GP; Finn DA
    Alcohol Clin Exp Res; 2013 May; 37(5):784-93. PubMed ID: 23278716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ability of baclofen to prevent somatic manifestations and neurochemical changes during nicotine withdrawal.
    Varani AP; Moutinho LM; Calvo M; Balerio GN
    Drug Alcohol Depend; 2011 Dec; 119(1-2):e5-12. PubMed ID: 21733642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intrahippocampal nicotine and neurosteroid administration on withdrawal in voluntary and chronic alcohol-drinking rats.
    Martin-Garcia E; Pallares M
    Alcohol Clin Exp Res; 2005 Sep; 29(9):1654-63. PubMed ID: 16205365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurosteroid allopregnanolone mediates anxiolytic effect of etifoxine in rats.
    Ugale RR; Sharma AN; Kokare DM; Hirani K; Subhedar NK; Chopde CT
    Brain Res; 2007 Dec; 1184():193-201. PubMed ID: 17950705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of co-administration of bupropion and nicotine or D-amphetamine on the elevated plus maze test in mice.
    Biala G; Kruk M
    J Pharm Pharmacol; 2009 Apr; 61(4):493-502. PubMed ID: 19298697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin mediates beneficial effects of Hypericum perforatum on nicotine withdrawal signs.
    Mannucci C; Pieratti A; Firenzuoli F; Caputi AP; Calapai G
    Phytomedicine; 2007 Oct; 14(10):645-51. PubMed ID: 17689233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.